Views

CrossRef citations to date

Altmetric

Original Articles: Clinical

A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia

Etan OrgelChildren’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles, Los Angeles, CA, USA; ;Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Correspondence[email protected]

http://orcid.org/0000-0002-1487-6818

Nicole M. MueskeChildren’s Orthopaedic Center, Children’s Hospital Los Angeles, Los Angeles, CA, USA;

http://orcid.org/0000-0003-4459-8289

Richard SpostoChildren’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles, Los Angeles, CA, USA; ;Keck School of Medicine, University of Southern California, Los Angeles, CA, USA;

Vicente GilsanzKeck School of Medicine, University of Southern California, Los Angeles, CA, USA; ;Department of Radiology, Children’s Hospital Los Angeles, Los Angeles, CA, USA;

Tishya A. L. WrenKeck School of Medicine, University of Southern California, Los Angeles, CA, USA; ;Children’s Orthopaedic Center, Children’s Hospital Los Angeles, Los Angeles, CA, USA;

David R. FreyerChildren’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles, Los Angeles, CA, USA; ;Keck School of Medicine, University of Southern California, Los Angeles, CA, USA;

Anna M. ButturiniChildren’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles, Los Angeles, CA, USA; ;Keck School of Medicine, University of Southern California, Los Angeles, CA, USA;

Steven D. MittelmanKeck School of Medicine, University of Southern California, Los Angeles, CA, USA; ;Center for Endocrinology, Diabetes & Metabolism, Children’s Hospital Los Angeles, Los Angeles, CA, USA

show all

Abstract

Adolescents with acute lymphoblastic leukemia (ALL) develop osteopenia early in therapy, potentially exacerbated by high rates of concurrent Vitamin D deficiency. We conducted a randomized clinical trial testing a Vitamin D-based intervention to improve Vitamin D status and reduce bone density decline. Poor adherence to home supplementation necessitated a change to directly observed therapy (DOT) with intermittent, high-dose Vitamin D3 randomized versus standard of care (SOC). Compared to SOC, DOT Vitamin D3 successfully increased trough Vitamin 25(OH)D levels (p = .026) with no residual Vitamin D deficiency, 100% adherence to DOT Vitamin D3, and without associated toxicity. However, neither Vitamin D status nor supplementation impacted bone density. Thus, this adherence-optimized intervention is feasible and effective to correct Vitamin D deficiency in adolescents during ALL therapy. Repletion of Vitamin D and calcium alone did not mitigate osteopenia, however, and new, comprehensive approaches are needed to address treatment-associated osteopenia during ALL therapy.

Keywords:

Acknowledgements

The study team would like to thank our research coordinator, Swati Gulati, as well as Lisa Villanueva and Mercedes Lavanderia from the Department of Radiology, and the patients and families who participated on the clinical trial.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2017.1289526.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia

Information for

Open access

Opportunities

Help and information

A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia

Abstract

Acknowledgements

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature